| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Oct 2024 | 21 Oct 2024 |
| Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve 1. Audited Financial Results for the quarter and half year ended September 30 2024; 2. Any other business matter if required with the permission of Chair. Financial Results for the quarter and Half year ended September 30, 2024 (As Per BSE Announcement dated on 28.10.2024) | ||
| Board Meeting | 5 Aug 2024 | 29 Jul 2024 |
| Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve Audited Financial Results for the quarter ended June 30 2024 and any other business matter if required with the permission of Chair. Outcome of the Board Meeting Financial Results for the Quarter ended June 30, 2024 (As per BSE Announcement Dated on 05/08/2024) | ||
| Board Meeting | 13 May 2024 | 4 May 2024 |
| Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve Audited Financial Results for the quarter ended March 31 2024; Audited Financial Statements for the year ended March 31 2024; Recommend Final Dividend if any for the year ended March 31 2024; Approve any other business matter if required with the permission of Chair. Outcome of Board Meeting Appointment of Auditors (As Per BSE Announcement dated on 13.05.2024) | ||
| Board Meeting | 7 Feb 2024 | 30 Jan 2024 |
| Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve Audited Financial Results for the quarter and nine months ended December 31 2023 Interim Dividend if any for the FY 2023-24 and other business matters if any. Interim Dividend for FY 2023-24 Financial results and Interim dividend Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023 Record date for Interim dividend (As Per BSE Announcement Dated on 07.02.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
